| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |